Mary Looby
@maryloobypharmd
Critical Care / Anticoagulation Clinical Pharmacy Specialist | CVICU | Inova Heart and Vascular Institute
ID: 497344179
19-02-2012 22:00:02
195 Tweet
109 Followers
373 Following
Happening now #ISHLT2021, UNC 90-pt study, no ASA in #LVAD patients from implant reduces hemocompatibility related adverse events. 6-fold higher risk of bleeding with ASA, no increase in stroke. @bradbumm Nir Uriel, MD MSc Jennifer Cowger @manreetkanwar Rebecca Cogswell Khue Ton
Way to go Ian B. Hollis 👏🏻👏🏻. Moving in the right direction where less is more.
One of the most exciting things I’ve been a part of in my career. 🤩 Cannot wait to share what we learn @IHVInews Palak Shah #DOACLVAD
Matt Dimond Journal of Cardiac Failure Mary Looby Christopher O'Connor @IHVInews Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Mitchell Psotka Iyad Isseh إياد نبيل العسّة Jamie Kennedy Major reduction in bleeding with #ARIES trial in #LVAD pts. Now let’s improve #QOL and healthcare burden with #DOAC therapy. Read the DOAC LVAD study design paper. Jennifer Cowger @manreetkanwar Tom Cascino, MD Rebecca Cogswell Keyur B. Shah